.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Covington
Boehringer Ingelheim
AstraZeneca
Teva
Federal Trade Commission
Medtronic
Moodys
Johnson and Johnson
Deloitte

Generated: November 18, 2017

DrugPatentWatch Database Preview

SALONPAS Drug Profile

« Back to Dashboard

What is the patent landscape for Salonpas, and when can generic versions of Salonpas launch?

Salonpas is a drug marketed by Hisamitsu Pharm Co and is included in one NDA. There are two patents protecting this drug.

This drug has eighteen patent family members in fourteen countries.

The generic ingredient in SALONPAS is menthol; methyl salicylate. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menthol; methyl salicylate profile page.

Summary for SALONPAS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-001Feb 20, 2008OTCYesYes► Subscribe► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-002Nov 5, 2012OTCYesNo► Subscribe► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-001Feb 20, 2008OTCYesYes► Subscribe► SubscribeY ► Subscribe
Hisamitsu Pharm Co
SALONPAS
menthol; methyl salicylate
PATCH;TOPICAL022029-002Nov 5, 2012OTCYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: SALONPAS

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,455,376Adhesive preparation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: SALONPAS

Country Document Number Estimated Expiration
BrazilPI0712396► Subscribe
World Intellectual Property Organization (WIPO)2008016077► Subscribe
Australia2007279643► Subscribe
China101442993► Subscribe
JapanWO2008016077► Subscribe
South Korea20090035474► Subscribe
Russian Federation2441649► Subscribe
Malaysia149142► Subscribe
TaiwanI414299► Subscribe
Singapore174034► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Citi
Colorcon
Cerilliant
UBS
Julphar
Queensland Health
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot